Generic drug maker Mylan has settled with Orion over a drug used to treat Parkinson's disease, Mylan said Thursday
Indian generic drug maker Wockhardt received three new drug approvals from the Food and Drug Administration, agency records show.
Patients taking an experimental treatment for Parkinson's disease experienced greater reduction in symptoms than those taking standard therapies, according to results of a late-stage clinical trial.
The branded drugs division of Impax Labs has finished enrolling patients in a late-stage trial of a drug for Parkinson’s disease.
Data from a long-term clinical trial may indicate a possible cancer risk in men taking...